[1]
Nazish Abbas and R. Jabeen, “Hardships of drugs monitoring – Ambiguities in pharmacovigilance (PV) rules 2018 and guidelines 2019 in the Pakistan”, J Pak Med Assoc, vol. 71, no. 10, pp. 2481–2482, Aug. 2021.